Drawing for Serial No. 79250534

USPTO serial 79250534

Serial No. 79250534

Reviewed by CopyMark Law Group

Reg. 5940694Status 709
Filing date
Status date
Registration date
Dec 24, 2019
Examiner
SULLIVAN, JOHN C
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79250534?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

M. Scott Alprin

M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Surface-active chemical agent for general use in the industrial arts, namely, as wetting, spreading, emulsifying, dispersing and penetrating agents; industrial chemicals; chemical preparations for scientific purposes; chemical preparations for use in photography; diagnostic reagents for scientific or research use; reagents for chemical analyses, other than for medical or veterinary purposes; in vitro diagnostic reagents for scientific purposes; diagnostic reagents and preparations, except for medical or veterinary use; antibodies for scientific purposes, other than for medical or veterinary use, namely, laboratory chemicals in the nature of an antibody reagent used for the preparation or purification of antigens from biological fluids, and the detection of antigens in cell and tissue analysis for in vitro diagnostic use; reagents for testing the sterility of medical equipment; reagents for scientific purposes for use in nucleic acid isolation and purification; assays for research purposes; diagnostic reagents, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; buffer solutions for use in analytical chemistry; standard solutions for use in analytical chemistry; chemicals for use in chromatography; rheology modifiers, namely, chemicals for use in the field of coating materials; chemicals, namely, cellulose derivatives in the nature of cellulose; chemicals for use in the processing of plastics; chemical preparations, namely, salt in the nature of hydrochloride, acetates and sulfonates; chemicals for use in the treatment of waste water; chemicals for use in the manufacture of confectionery; chemicals for the manufacture of pigments; condensation-preventing chemicals; chemicals for use in metal plating; chemicals for use in the manufacture of synthetic rubber; chemicals for use in the manufacture of paper; chemicals for photographic film processing; chemicals for use in the treatment of water; chemicals for use in aquaria; chemicals for use in the manufacture of adhesives; chemicals for the manufacture of paints; waste water treatment chemicals for industrial purposes; chemicals for use in the manufacture of fabric and textiles; chemicals for treating hazardous wasteSECTION 71 - CANCELLED—
005In vitro diagnostic preparations for medical purposes; diagnostic preparations for medical purposes; diagnostic test reagents for medical purposes; biochemical preparations for medical purposes for hyperphosphatemia; biological reagents for medical purposes; biological preparations for medical purposes for cancer and autoimmune disease; chemical reagents for medical purposes; reagents for medical purposes; clinical diagnostic reagents for medical purposes; diagnostic agents, preparations and substances for infectious, parasitic diseases, cancer, neoplasms, diseases of the blood and blood-forming organs, certain disorders involving the immune mechanism, endocrine diseases, nutritional and metabolic diseases, diseases of the nervous system, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth, the puerperium, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities for medical purposes; chemical preparations for medical purposes for hyperphosphatemia; antibodies for medical purposes; diagnostic biomarker reagents for medical purposes; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis, stool analysis, sputum analysis, and pharyngeal swab analysis; serums in the nature of medical diagnostic test reagentsSECTION 71 - CANCELLED—
010Medical apparatus and instruments for diagnosing or treating respiratory conditions, namely, thermometer, electrocardiograph, heart rate monitor, sphygmomanometer and circulatory monitoring device; diagnostic apparatus for medical purposes for testing the amounts and types of DNA, RNA and proteins, the number of cells in clinical specimen sampled from blood, urine, saliva, stool, sputum, swab, cells, tissues and organisms; blood testing apparatus; apparatus for clinical diagnosis for testing the amounts and types of DNA, RNA and proteins, the number of cells in clinical specimen sampled from blood, urine, saliva, stool, sputum, swab, cells, tissues and organisms; analyzers, namely, apparatus for blood analysis, urine analysis, saliva analysis, stool analysis, sputum analysis, and swab analysis for pathogenic microorganisms identification for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 10, 2026C71TCANCELLED SECTION 71—
Dec 24, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 7, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 5, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 17, 2020FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 31, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 31, 2020FIMPFINAL DISPOSITION PROCESSED—
Mar 24, 2020FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 24, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 8, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 8, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 5, 2019GPNXNOTIFICATION PROCESSED BY IB—
Sep 18, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 18, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2019ALIEASSIGNED TO LIE—
Aug 29, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Aug 29, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 29, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 29, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 5, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 2, 2019RFNTREFUSAL PROCESSED BY IB—
Feb 11, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 11, 2019RFRRREFUSAL PROCESSED BY MPU—
Feb 5, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 4, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 3, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 1, 2019DOCKASSIGNED TO EXAMINER—
Feb 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 31, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance